Kathleen Moore, MD
Enriched profileProfessor, Department of Obstetrics and Gynecology; Deputy Director and Director of Phase I Clinical Trials, Fred & Pamela Buffett Cancer Center · University of Nebraska Medical Center
Kathleen Moore is Professor, Department of Obstetrics and Gynecology; Deputy Director and Director of Phase I Clinical Trials, Fred & Pamela Buffett Cancer Center at University of Nebraska Medical Center. OpenAlex indexes 1,026 publications with 47,487 citations (h-index 84); ClinicalTrials.gov lists 22 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Gynecologic Oncology profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Kathleen N. Moore, MD, is Professor, Department of Obstetrics and Gynecology at University of Nebraska Medical Center, Fred & Pamela Buffett Cancer Center (Omaha, NE). The public record shows 1,026 publications with 47,487 citations (h-index 84), centered on Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Endometrial and Cervical Cancer Treatments. It also documents an investigator role on 22 registered clinical trials, industry payments reported by 41 companies, 6 NIH-funded awards (2017–2026).
- Most recent indexed publication: 2026 · Nature reviews. Clinical oncology
- Top research focus: Ovarian cancer diagnosis and treatment
- 22 registered trials on ClinicalTrials.gov
- Open Payments reporting from 41 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 39 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 336.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 22 registered studies on ClinicalTrials.gov. The most recent:
- Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer
Sponsor: University of Oklahoma
- Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Sponsor: Washington University School of Medicine
Industry payments
Updated 27 Aug 2026
41 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20255 payments$25,108openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202512 payments$23,661openpaymentsdata.cms.gov ↗
- Daiichi Sankyo Company LTDProgram year20257 payments$21,456openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Poly(ADP-Ribose) Polymerase Inhibitor100%Lynparza100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
6 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Antibody-drug conjugates in gynaecological cancers: opportunities and challenges.
Nature reviews. Clinical oncology
Review2026 - New standards and new constraints redefine treatment sequencing in platinum-resistant ovarian cancer.
Nature reviews. Clinical oncology
Article2026 - Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.
Clinical cancer research
Clinical Trial2026 - Decoding the End Points of Poly (ADP-ribose) Polymerase Inhibitor Trials in Ovarian Cancer.
Journal of clinical oncology
Letter2025 - Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.
Journal of clinical oncology
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/scientific-contributions/Kathleen-N-Moore-39995420
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
ocrahope.org/about/team/scientific-advisory-committee/kathleen-moore
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocrahope.org ↗ - Other
unmc.edu/newsroom/2026/03/18/kathleen-moore-md-appointed-cancer-centers-deputy-director
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - Apple Podcasts
podcasts.apple.com/us/podcast/gynecologic-oncology-interview-with-kathleen-moore-md/id699146770
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of Washington School of Medicine, Seattle, WA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - MS in Epidemiology
University of Oklahoma Health Sciences Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - Residency in Obstetrics and Gynecology
Magee-Womens Hospital, University of Pittsburgh Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - Fellowship in Gynecologic Oncology
University of Oklahoma Health Sciences Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asco.org ↗
- Member
Board of Directors, American Society of Clinical Oncology (ASCO); began a four-year term in the Designated Surgical Oncologist seat starting June 2023
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →connection.asco.org ↗ - Member
Board of Directors, GOG Foundation (Gynecologic Oncology Group Foundation)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocrahope.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →expertperspectives.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →expertperspectives.com ↗
Secondary affiliations
appointments beyond the home institution- Virginia Kerley Cade Endowed Chair in Cancer Development and Professor of Gynecologic Oncology
University of Oklahoma Health Sciences Center / OU Health Stephenson Cancer Center (prior institution …
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocrahope.org ↗ - Former Deputy Director and Associate Director for Clinical Research
OU Health Stephenson Cancer Center; former Director, Oklahoma TSET Phase I Program (Oklahoma City)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unmc.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
James Armitage, MD
University of Nebraska Medical Center
Julie Vose, MD
University of Nebraska Medical Center
Ted Mikuls, MD
University of Nebraska Medical Center
Jean Grem, MD
University of Nebraska Medical Center